These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
572 related items for PubMed ID: 16460776
21. Viral evolution in macaques coinfected with CCR5- and CXCR4-tropic SHIVs in the presence or absence of vaccine-elicited anti-CCR5 SHIV neutralizing antibodies. Burke B, Derby NR, Kraft Z, Saunders CJ, Dai C, Llewellyn N, Zharkikh I, Vojtech L, Zhu T, Srivastava IK, Barnett SW, Stamatatos L. Virology; 2006 Nov 25; 355(2):138-51. PubMed ID: 16920175 [Abstract] [Full Text] [Related]
22. DNA vaccination of macaques by a full genome HIV-1 plasmid which produces noninfectious virus particles. Akahata W, Ido E, Shimada T, Katsuyama K, Yamamoto H, Uesaka H, Ui M, Kuwata T, Takahashi H, Hayami M. Virology; 2000 Sep 15; 275(1):116-24. PubMed ID: 11017793 [Abstract] [Full Text] [Related]
23. Inclusion of a CRF01_AE HIV envelope protein boost with a DNA/MVA prime-boost vaccine: Impact on humoral and cellular immunogenicity and viral load reduction after SHIV-E challenge. Cox JH, Ferrari MG, Earl P, Lane JR, Jagodzinski LL, Polonis VR, Kuta EG, Boyer JD, Ratto-Kim S, Eller LA, Pham DT, Hart L, Montefiori D, Ferrari G, Parrish S, Weiner DB, Moss B, Kim JH, Birx D, VanCott TC. Vaccine; 2012 Feb 27; 30(10):1830-40. PubMed ID: 22234262 [Abstract] [Full Text] [Related]
24. Heterologous neutralizing antibody induction in a simian-human immunodeficiency virus primate model: lack of original antigenic sin. Rasmussen RA, Montefiori DC, Robinson HL, McClure HM, Ruprecht RM. J Infect Dis; 2001 Dec 15; 184(12):1603-7. PubMed ID: 11740737 [Abstract] [Full Text] [Related]
26. Robust HIV-specific immune responses were induced by DNA vaccine prime followed by attenuated recombinant vaccinia virus (LC16m8 strain) boost. Shinoda K, Xin KQ, Kojima Y, Saha S, Okuda K, Okuda K. Clin Immunol; 2006 Apr 15; 119(1):32-7. PubMed ID: 16458074 [Abstract] [Full Text] [Related]
27. Cytokine-induced augmentation of DNA vaccine-elicited SIV-specific immunity in rhesus monkeys. Barouch DH, Letvin NL. Dev Biol (Basel); 2000 Apr 15; 104():85-92. PubMed ID: 11713828 [Abstract] [Full Text] [Related]
28. Prime-boost vaccination with plasmid DNA and a chimeric adenovirus type 5 vector with type 35 fiber induces protective immunity against HIV. Xin KQ, Jounai N, Someya K, Honma K, Mizuguchi H, Naganawa S, Kitamura K, Hayakawa T, Saha S, Takeshita F, Okuda K, Honda M, Klinman DM, Okuda K. Gene Ther; 2005 Dec 15; 12(24):1769-77. PubMed ID: 16079886 [Abstract] [Full Text] [Related]
29. Protection from immunodeficiency virus challenges in rhesus macaques by multicomponent DNA immunization. Kim JJ, Yang JS, Nottingham LK, Lee DJ, Lee M, Manson KH, Wyand MS, Boyer JD, Ugen KE, Weiner DB. Virology; 2001 Jul 05; 285(2):204-17. PubMed ID: 11437655 [Abstract] [Full Text] [Related]
30. Prime-boost strategies in DNA vaccines. Dale CJ, Thomson S, De Rose R, Ranasinghe C, Medveczky CJ, Pamungkas J, Boyle DB, Ramshaw IA, Kent SJ. Methods Mol Med; 2006 Jul 05; 127():171-97. PubMed ID: 16988455 [Abstract] [Full Text] [Related]
31. Potent specific immune responses induced by prime-boost-boost strategies based on DNA, adenovirus, and Sendai virus vectors expressing gag gene of Chinese HIV-1 subtype B. Yu S, Feng X, Shu T, Matano T, Hasegawa M, Wang X, Ma H, Li H, Li Z, Zeng Y. Vaccine; 2008 Nov 11; 26(48):6124-31. PubMed ID: 18812199 [Abstract] [Full Text] [Related]
32. Neutralizing antibodies elicited by immunization of monkeys with DNA plasmids and recombinant adenoviral vectors expressing human immunodeficiency virus type 1 proteins. Mascola JR, Sambor A, Beaudry K, Santra S, Welcher B, Louder MK, Vancott TC, Huang Y, Chakrabarti BK, Kong WP, Yang ZY, Xu L, Montefiori DC, Nabel GJ, Letvin NL. J Virol; 2005 Jan 11; 79(2):771-9. PubMed ID: 15613305 [Abstract] [Full Text] [Related]
33. HIV-1 DNA/MVA vaccination reduces the per exposure probability of infection during repeated mucosal SHIV challenges. Ellenberger D, Otten RA, Li B, Aidoo M, Rodriguez IV, Sariol CA, Martinez M, Monsour M, Wyatt L, Hudgens MG, Kraiselburd E, Moss B, Robinson H, Folks T, Butera S. Virology; 2006 Aug 15; 352(1):216-25. PubMed ID: 16725169 [Abstract] [Full Text] [Related]
34. Cellular and humoral immune responses to a canarypox vaccine containing human immunodeficiency virus type 1 Env, Gag, and Pro in combination with rgp120. AIDS Vaccine Evaluation Group 022 Protocol Team. J Infect Dis; 2001 Feb 15; 183(4):563-70. PubMed ID: 11170981 [Abstract] [Full Text] [Related]
35. Immune responses but no protection against SHIV by gene-gun delivery of HIV-1 DNA followed by recombinant subunit protein boosts. Putkonen P, Quesada-Rolander M, Leandersson AC, Schwartz S, Thorstensson R, Okuda K, Wahren B, Hinkula J. Virology; 1998 Oct 25; 250(2):293-301. PubMed ID: 9792840 [Abstract] [Full Text] [Related]
37. HIV-1 vaccines based on replication-competent Tiantan vaccinia protected Chinese rhesus macaques from simian HIV infection. Liu Q, Li Y, Luo Z, Yang G, Liu Y, Liu Y, Sun M, Dai J, Li Q, Qin C, Shao Y. AIDS; 2015 Mar 27; 29(6):649-58. PubMed ID: 25849828 [Abstract] [Full Text] [Related]